Advances in Alzheimer's disease
- PMID: 2001787
Advances in Alzheimer's disease
Abstract
The problem of the etiology of Alzheimer's disease has not been solved. But in the past several years there have been significant extensions of our knowledge of the disease and advances in determining the molecular changes underlying the disorder. There is now convincing evidence that the dementia per se is caused by loss of neurons and synapses, particularly in neocortex and hippocampus. The molecular aspects of amyloid and its precursor protein have been defined. The nature of intracellular changes leading to accumulation of the paired helical filament is beginning to be understood. For the first time, putative risk factors can be described in terms of pathogenetic mechanisms. Thus, it may become possible in the not-too-distant future to discover interventions that will slow the progress of this devastating disease.
Similar articles
-
Molecular relation of amyloid filaments and paired helical filaments in Alzheimer's disease.Adv Neurol. 1990;51:171-9. Adv Neurol. 1990. PMID: 2104686 Review. No abstract available.
-
The amyloid peptide and its precursor in Alzheimer's disease.Rev Neurosci. 1995 Oct-Dec;6(4):287-316. Rev Neurosci. 1995. PMID: 8845971 Review.
-
[Pathogenetic factors of Alzheimer disease].Z Gerontol Geriatr. 1995 May-Jun;28(3):155. Z Gerontol Geriatr. 1995. PMID: 7664189 Review. German.
-
[Physiopathology of dementia of the Alzheimer type: role of the amyloid beta-protein].Ann Med Psychol (Paris). 1992 Feb-Mar;150(2-3):131-7. Ann Med Psychol (Paris). 1992. PMID: 1343507 French.
-
Beyond amyloid: the next generation of Alzheimer's disease therapeutics.Mol Interv. 2007 Oct;7(5):261-70. doi: 10.1124/mi.7.5.8. Mol Interv. 2007. PMID: 17932415 Review.
Cited by
-
Concurrent administration of donepezil HCl and digoxin: assessment of pharmacokinetic changes.Br J Clin Pharmacol. 1998 Nov;46 Suppl 1(Suppl 1):40-4. doi: 10.1046/j.1365-2125.1998.0460s1040.x. Br J Clin Pharmacol. 1998. PMID: 9839765 Free PMC article. Clinical Trial.
-
Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.Neurochem Res. 1997 Apr;22(4):523-7. doi: 10.1023/a:1027380331807. Neurochem Res. 1997. PMID: 9130265 Review.
-
Uric Acid and the Risk of Alzheimer's Disease: Is There an Association?Am J Alzheimers Dis Other Demen. 2016 May;31(3):294-5. doi: 10.1177/1533317515602550. Epub 2015 Sep 17. Am J Alzheimers Dis Other Demen. 2016. PMID: 26385943 Free PMC article.
-
Allopregnanolone attenuates Aβ25-35-induced neurotoxicity in PC12 cells by reducing oxidative stress.Int J Clin Exp Med. 2015 Aug 15;8(8):13610-5. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26550302 Free PMC article.
-
New Sulfonate Ester-Linked Fluorinated Hydrazone Derivatives as Multitarget Carbonic Anhydrase and Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, Molecular Docking and ADME Analysis.Chem Biodivers. 2024 Dec;21(12):e202401849. doi: 10.1002/cbdv.202401849. Epub 2024 Oct 18. Chem Biodivers. 2024. PMID: 39159154 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous